Lofaro Danilo, Vogelzang Judith L, van Stralen Karlijn J, Jager Kitty J, Groothoff Jaap W
Pediatr Nephrol. 2016 Feb;31(2):315-23. doi: 10.1007/s00467-015-3209-0.
Pediatric renal replacement therapy (RRT) patients surviving long-term are at a much higher risk of mortality compared with the age-matched general population. Recently, we demonstrated a transition from cardiovascular disease to infection as the main cause of death in a long-term follow-up study of pediatric RRT. Here, we explore the burden of infections requiring hospitalization over 30 years of follow-up on RRT.
The cohort comprised all 234 Dutch patients on RRT under 15 years of age between 1972 and 1992. We analyzed infection-related hospitalizations during the period 1980–2010. We evaluated the Hospital Admission Rate (HAR) per patient-years (py) and infectious over noninfectious HAR ratio (HARR).
The HAR decreased significantly over time for all patients. The rate of hemodialysis-related infections decreased between 1980 and 1999, but stabilized during 2000–2010, whereas peritoneal dialysis-related infections decreased progressively. Transplantation-related infections did not change, except for urinary tract infections (UTIs), which increased significantly from 3.3/100 py [95%CI 3.2–3.4] in 1980–1989 to 4.4/100 py [4.2–4.5] in 2000–2010 (p <0.001). The contribution of infection to HAR increased significantly in transplanted patients (HARR: 1980–1989: 0.25 [0.2–0.3]; 2000–2010: 1.0 [0.79–1.27], p <0.001).
Our findings indicate a relative increase in infections requiring hospitalization over time in patients starting RRT during the pediatric age, especially severe UTIs in transplantation. More attention paid to urological abnormalities in cases of recurrent UTI and tailored adjustment of immunosuppression may reduce risk in these patients.
与年龄匹配的普通人群相比,长期存活的儿科肾脏替代治疗(RRT)患者的死亡风险要高得多。最近,我们在一项儿科RRT长期随访研究中证明,死亡的主要原因已从心血管疾病转变为感染。在此,我们探讨在30年的RRT随访期间需要住院治疗的感染负担。
该队列包括1972年至1992年间所有234名15岁以下接受RRT治疗的荷兰患者。我们分析了1980年至2010年期间与感染相关的住院情况。我们评估了每位患者每年的住院率(HAR)以及感染性住院率与非感染性住院率之比(HARR)。
所有患者的HAR随时间显著下降。1980年至1999年间,血液透析相关感染率下降,但在2000年至2010年间趋于稳定,而腹膜透析相关感染率则逐渐下降。除尿路感染(UTIs)外,移植相关感染没有变化,尿路感染从1980年至1989年的3.3/100人年[95%CI 3.2 - 3.4]显著增加至2000年至2010年的4.4/100人年[4.2 - 4.5](p<0.001)。在移植患者中,感染对HAR的贡献显著增加(HARR:1980年至1989年:0.25[0.2 - 0.3];2000年至2010年:1.0[0.79 - 1.27],p<0.001)。
我们的研究结果表明,儿科时期开始接受RRT治疗的患者中,需要住院治疗的感染随时间相对增加,尤其是移植患者中的严重UTIs。对于复发性UTI病例,更多关注泌尿系统异常并针对性调整免疫抑制可能会降低这些患者的风险。